Bicycle Therapeutics plc American Depositary Shares vs. Johnson & Johnson
BCYC
Bicycle Therapeutics plc American Depositary Shares
$4.20 -3.00%
VS JNJJohnson & Johnson
$268.04 +0.85%
Bicycle Therapeutics plc American Depositary Shares (BCYC) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BCYC | JNJ | |
|---|---|---|
| Market Cap | $303.07 million | $640.48 billion |
| Revenue (TTM) | — | $97.93 billion |
| Net Income (TTM) | — | $21.04 billion |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| BCYC | JNJ | |
|---|---|---|
| P/E Ratio | — | 31.10 |
| Price / Book | 0.59 | 7.54 |
| Price / Sales | — | 6.54 |
BCYC leads on 1 of 1 valuation factors.
Profitability
| BCYC | JNJ | |
|---|---|---|
| Net Margin | — | 21.48% |
| Return on Equity | — | 24.76% |
BCYC and JNJ split the profitability factors evenly.
Dividend
| BCYC | JNJ | |
|---|---|---|
| Dividend Yield | — | 2.00% |
| Payout Ratio | — | 62.18 |
BCYC and JNJ split the dividend factors evenly.
Risk & Sentiment
| BCYC | JNJ | |
|---|---|---|
| Short Interest | 0.00% | 0.67% |
BCYC leads on 1 of 1 risk & sentiment factors.
Dig deeper: BCYC overview, BCYC financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.